All Related Articles for: Unlock Longevity: How Data Slows Aging
-
FDA Approves First Oral GLP-1 Drug from Eli Lilly
The FDA has approved Eli Lilly's Foundayo, a new…
Read More » -
New GLP-1 Side Effect Emerges, Surpassing ‘Ozempic Face’
A new and distressing side effect of GLP-1 drugs…
Read More » -
How AI Digital Twins Are Transforming Diabetes and Obesity Care
Innovative digital health solutions use a personalized, data-driven approach…
Read More » -
Influencers Pushing Peptides: What’s the Real Risk?
Social media influencers are promoting dangerous at-home mixing of…
Read More » -
Study: No Safe Exit for Some on GLP-1 Drugs
GLP-1 weight-loss medications lack a clear, evidence-based strategy for…
Read More » Ex-X CEO Linda Yaccarino Takes Helm at Health Tech Firm eMed
Linda Yaccarino, former CEO of X, has joined eMed…
Read More »
